✦ LIBER ✦

Steady state disposition of chloroquine in patients with rheumatoid disease

✍ Scribed by M. Frisk-Holmberg; Y. Bergqvist; B. Domeij-Nyberg

Publisher: Springer
Year: 1983
Tongue: English
Weight: 214 KB
Volume: 24
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00607097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steady-state serum salicylate levels in

Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis

✍ Sidney Cassell; Daniel Furst; Sydney Dromgoole; Harold Paulus 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 2 views

Chloroquine reduces the bioavailability

Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis

✍ Peter Seideman; Freidoun Albertioni; Olof Beck; Staffan Eksborg; Curt Peterson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 2 views

Disposition of valproic acid in patients

Disposition of valproic acid in patients with liver disease

✍ U. Klotz; T. Rapp; W. A. Müller 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 670 KB

Chloroquine levels in blood during chron

Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis

✍ P. Augustijns; P. Geusens; N. Verbeke 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 480 KB

Blood levels of racemic chloroquine and its main metabolites desethylchloroquine and bisdesethylchloroquine were measured in 29 patients treated chronically for rheumatoid arthritis. In six patients, the concentrations were followed during a one day dosage interval. There was considerable intersubje

Disposition of antipyrine in patients wi

Disposition of antipyrine in patients with extensive metastatic liver disease

✍ G.-M. Robertz-Vaupel; K. D. Lindecken; T. Edeki; C. Funke; S. Belwon; H. J. Deng 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 536 KB

In the present study the effect of metastatic liver disease on hepatic drug metabolism has been examined by studying the pharmacokinetics of antipyrine and the urinary excretion of antipyrine and its three major metabolites (4-hydroxyantipyrine, norantipyrine, and 3-hydroxymethylantipyrine) in 12 pa

Steady state pharmacokinetics of piroxic

Steady state pharmacokinetics of piroxicam in children with rheumatic diseases

✍ A.-L. Mäkelä; K. T. Olkkola; M. J. Mattila 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 238 KB

Ten children with rheumatoid arthritis, aged 7-16 y and weighing 20-63 kg, were treated with piroxicam mean dose 0.4 mg.kg-1 once daily for 2 weeks. On Day 15, blood was sampled from 2-120 h after the last dose. The Cmax for piroxicam ranged from 3.6 to 9.8 (mean 6.6) mg.l-1 and its half-life by log